Clinical and Diagnostic Laboratory Immunology, July 1999, p. 525-529, Vol. 6, No. 4
1071-412X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Division of Neonatology,1 Division of Immunologic and Infectious Diseases,2 and Clinical Immunology Laboratories,3 Department of Pediatrics, University of Pennsylvania School of Medicine, The Children's Hospital of Philadelphia, Joseph Stokes Jr. Research Institute, Philadelphia, Pennsylvania 19104-4399
Received 3 August 1998/Returned for modification 27 October 1998/Accepted 30 March 1999
| |
ABSTRACT |
|---|
|
|
|---|
Preterm infants have an increased incidence of infection, which is
principally due to deficiencies in neonatal host defense mechanisms.
Monocyte adherence is important in localizing cells at sites of
infection and is associated with enhanced antimicrobial functions. We
isolated cord blood monocytes from preterm and full-term infants to
study their adhesion and immune functions, including superoxide
(O2
) generation, degranulation, and cytokine
secretion and their adhesion receptors. O2
production and degranulation were significantly diminished, by 28 and
37%, respectively, in adherent monocytes from preterm infants compared
to full-term infants (P < 0.05); however, these
differences were not seen in freshly isolated cells. We also observed a
significant decrease of 35% in tumor necrosis factor alpha secretion
by lipopolysaccharide-stimulated adherent monocytes from preterm
infants compared to full-term infants (P < 0.05);
however, this difference was not observed in interleukin-1
or
interleukin-6 production by the monocytes. The cell surface expression
of the CD11b/CD18 adhesion receptor subunits was significantly
decreased (by 60 and 52%, respectively) in monocytes from preterm
infants compared to full-term infants (P < 0.01). The
cascade of the immune response to infection involves monocyte
upregulation and adherence via CD11b/CD18 receptors followed by cell
activation and the release of cytokines and bactericidal products. We
speculate that monocyte adherence factors may be important in the
modulation of immune responses in preterm infants.
| |
INTRODUCTION |
|---|
|
|
|---|
Despite advances in antimicrobial therapy, immunotherapy, and neonatal intensive care, preterm infants have a 10-fold-higher risk of mortality from infection than full-term infants (7, 11, 13). The increased susceptibility to infection is multifactorial, but it is principally due to deficiencies in neonatal host defense mechanisms. These functions have been well studied in monocytes derived from adults and full-term infants but not in monocytes from preterm infants (5, 20, 23).
The monocyte is crucial in the immune response to infection, playing a
role in antigen presention, phagocytosis, bactericidal activity, and
secretory function (23). In response to inflammatory stimuli, monocytes first localize at sites of infection. Localization is mediated by adherence via the CD11b/CD18 receptor on the surfaces of
monocytes and intercellular adhesion molecule 1 on the endothelium. These activated monocytes transport additional CD11b/CD18 receptors from intracellular compartments to the cell surface membrane to enhance
adhesion and upregulate immune function (19). The
intravascular monocytes then migrate from the endothelium to the
extravascular site of infection. At the site of infection, bactericidal
activity includes the production of oxygen radicals via the respiratory burst, specifically O2
, and degranulation
with the release of granule contents, including lysozyme (2, 12,
20). These functions are further enhanced by the secretion of
proinflammatory cytokines, including tumor necrosis factor (TNF),
interleukin-1 (IL-1), and IL-6 from activated monocytes at the site of infection.
We hypothesized that adherent monocytes from preterm infants may have
reduced O2
generation, degranulation, and
cytokine secretion. These diminished immune responses may be related to
deficiencies in adhesion factors at the sites of infection, such as the
decreased expression of the CD11b/CD18 molecule. The purposes of this
study were (i) to compare O2
production and
lysozyme release of adherent and freshly isolated monocytes from
preterm and full-term infants, (ii) to determine TNF-
, IL-1
, and
IL-6 secretion by adherent monocytes in response to lipopolysaccharide
(LPS), and (iii) to examine the cell surface expression of the
CD11b/CD18 adhesion receptor in monocytes from preterm and full-term infants.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Monocyte isolation. Cord blood was collected in heparinized syringes from placentas of preterm and full-term infants at delivery. Monocytes were isolated and purified as previously described by Hassan et al. (10). Whole blood was layered on lymphocyte separation medium (Organon Teknika, Durham, N.C.), followed by centrifugation at 500 × g for 45 min at room temperature. The band containing the peripheral blood mononuclear cells was carefully aspirated and then transferred to gelatin-coated flasks for monocyte adherence. After 45 min in 5% CO2 at 37°C, the flasks were washed with Dulbecco's modified Eagle medium (DMEM; GIBCO Laboratories, Grand Island, N.Y.) to remove the lymphocytes and nonadherent cells. Monocytes were then detached by exposure to 10 mM EDTA in DMEM containing 20% fetal calf serum (HyClone Laboratories, Logan, Utah) for 15 min. Monocytes were recovered by aspirating the flasks, followed by centrifugation for 10 min at 4°C. The pellet was resuspended in DMEM containing 20% fetal calf serum and 1% penicillin-streptomycin-L-glutamine.
Freshly isolated monocytes.
Freshly isolated monocytes were
defined as cells that were stimulated immediately after isolation.
Cells at a density of 0.5 × 106 monocytes per well in
96-well plates were used for measurement of
O2
production, and cells at a concentration
of 1 × 106 monocytes per ml in polystyrene tubes were
used for degranulation assays.
Adherent monocytes.
Adherent monocytes were defined as
monocytes that were cultured for 18 h in a humidified atmosphere
containing 5% CO2 at 37°C prior to the
O2
production and degranulation assays. Cells
were plated at a concentrations of 0.5 × 106
monocytes per well in 96-well plates for O2
production and 1.0 × 106 monocytes per well in
48-well plates for degranulation.
O2
generation.
Triplicate samples
of 0.5 × 106 cells per well were stimulated with
phorbol myristate acetate (PMA) (1.0 µg/ml) or N-formyl methionyl leucyl phenylalanine (FMLP) (10
6 M) for both
freshly isolated and adherent monocytes. O2
generation was measured as superoxide dismutase-inhibitable cytochrome c reduction by a continuous recording method over 15 min
starting at the time of stimulation (14).
O2
generation was expressed as nanomoles of
O2
per 106 cells.
Degranulation.
Monocytes (106 cells per well)
were analyzed immediately after isolation (freshly isolated cells) or
after incubation for 18 h in tissue culture wells (adherent
cells). Freshly isolated cells were distributed in polystyrene tubes
and pretreated with cytochalasin B (50 µg/ml). Triplicate samples
were stimulated with FMLP (10
6 M), and a second group of
triplicate samples were treated with Triton X-100 (0.2% final
concentration; Sigma, St. Louis, Mo.). Both groups were placed in a
37°C shaking bath for 30 min. Tubes were centrifuged at 1,200 rpm for
5 min, and the supernatant was collected. For adherent monocytes, the
medium was replaced after 18 h of incubation with fresh medium,
and then cells were treated with cytochalasin B (50 µg/ml) in tissue
culture wells. Triplicate samples were stimulated with FMLP
(10
6 M) or treated with Triton X-100 (0.2% final
concentration) in tissue culture wells for 30 min in 5%
CO2 at 37°C. Supernatants were collected from both
freshly isolated and adherent monocytes and then incubated with
Micrococcus lysodeikticus. Lysozyme release was measured as
the decrease in absorbance at 450 nm. Percent degranulation was
calculated as the change in absorption of FMLP-treated samples
(stimulated degranulation) divided by the change in absorption of
Triton X-100-treated samples (total degranulation).
TNF-
, IL-1
, and IL-6 production by monocytes.
Adherent
monocytes were stimulated with LPS (10 ng/ml; Sigma) and then cultured
in 5% CO2 at 37°C for 18 h. Supernatants were collected and stored at
70°C until analyzed. TNF-
(Genzyme, Cambridge, Mass.), IL-1
(Cistron, Pine Brook, N.J.), and IL-6 (Genzyme) levels were determined by enzyme-linked immunosorbent assay
with kits from the above-mentioned companies.
Adhesion receptor expression. Whole blood was collected in heparinized syringes from preterm and full-term placentas. Fluorescein isothiocyanate-conjugated monoclonal antibodies to CD11b (Immunotech, Westbrook, Maine), CD18 (Caltag, San Francisco, Calif.), and CD14 (Immunotech) cell surface receptors were added to 100 µl of whole blood and incubated for 30 min at 4°C in the dark. After ammonium chloride lysis, cells were fixed in 1% paraformaldehyde, and fluorescence intensity was measured by flow cytometry (Epics Elite flow cytometer; Coulter, Miami, Fla.). Expression of the monocyte-specific marker CD14 was used as a gating criterion to identify monocytes in whole-blood preparations. Instrument calibration was performed prior to the evaluation of patient and control specimens with DNA check microspheres (Coulter Immunotech, Hialeah, Fla.). Two thousand cells were counted for each antibody, and cell surface receptor expression was quantitated as mean channel fluorescence (MCF). Whole blood from healthy adult donors was used for reference points to standardize each assay.
Materials.
PMA was purchased from Sigma, stored as a
concentrated stock solution in dimethyl sulfoxide (1 mg/ml), and
diluted before use. Cytochalasin B (Sigma) was stored in a stock
solution of 10 mg/ml in dimethyl sulfoxide at
70°C. FMLP (Sigma)
was stored in a stock solution of ethanol (10
2 M) and
diluted in buffer before use. M. lysodeikticus was stored at
4°C in 0.1 M KH2PO4.
Statistical analysis.
Cytokine levels,
O2
production, percent degranulation, MCF,
and other variables were compared between patient groups by using the
independent t test. A probability of less than 0.05 was
considered significant.
| |
RESULTS |
|---|
|
|
|---|
Patient population. The study subjects were different for each assay, secondary to cell number as a limiting factor. In each assay there was a significant difference between preterm and full-term infant populations in both gestational age (GA) and birth weight (BW) (P < 0.001). For each assay, the specific patient population is reported.
O2
production.
Monocytes were
isolated from the cord blood of 21 full-term infants (mean BW ± standard error of the mean [SEM], 3,291 ± 85 g; GA,
39.5 ± 0.5 weeks) and 14 preterm infants (BW, 2,311 ± 148 g [P < 0.001]; GA, 34.7 ± 0.5 weeks
[P < 0.001]). The levels of O2
generated by adherent monocytes from
full-term infants were 8.0 ± 0.6 nmol of
O2
/106 cells after PMA
stimulation and 1.9 ± 0.6 nmol of
O2
/106 cells after FMLP
stimulation. O2
generation was significantly
lower for adherent monocytes from preterm infants: 5.8 ± 0.8 nmol
of O2
/106 cells (a 28% decrease)
with PMA (P < 0.05) and 1.4 ± 0.4 nmol of
O2
/106 cells (a 26% decrease)
with FMLP (P < 0.05) (Fig.
1).
|
production were 17.5 ± 4.4 nmol of
O2
/106 cells with PMA and
3.1 ± 1.1 nmol of O2
/106
cells after FMLP stimulation. O2
production
by freshly isolated monocytes from preterm infants was significantly
greater, 22.8 ± 2.7 nmol of
O2
/106 cells (a 30% increase)
with PMA (P < 0.05), but not significantly different
with FMLP (Fig. 2).
|
Degranulation. Cord blood monocytes were isolated from 11 full-term infants (BW, 3,340 ± 75 g; GA, 40.0 ± 0.9 weeks) and 4 preterm infants (BW, 2,432 ± 134 g [P < 0.001]; GA, 32.0 ± 1.5 weeks [P < 0.001]). Degranulation by adherent monocytes from full-term infants was 63.8% ± 6.9%. Degranulation by adherent monocytes from preterm infants was significantly lower, 40.1% ± 13.5% (a 37% decrease) (P < 0.05) (Fig. 1). There was no significant difference in the degranulation of lysozyme by freshly isolated monocytes from preterm infants (84.9% ± 9.7%) and full-term infants (66.3% ± 16.4%) (Fig. 2).
TNF-
, IL-1
, and IL-6 production.
Cord blood monocytes
were isolated from 21 full-term infants (BW, 3,291 ± 85 g;
GA, 39.5 ± 0.5 weeks) and 14 preterm infants (BW, 2,311 ± 148 g [P < 0.001]; GA, 34.7 ± 0.5 weeks
[P < 0.001]) to determine levels of cytokine
production. The level of TNF-
production by adherent monocytes from
full-term infants in response to LPS was 10,548 ± 996 pg/ml.
TNF-
production was significantly lower in adherent monocytes from
preterm infants, 6,875 ± 798 pg/ml (a decrease of 35%)
(P < 0.05) (Table 1).
The levels of IL-1
and IL-6 production by LPS-stimulated adherent
monocytes from full-term infants were 2,649 ± 168 and 8,515 ± 427 pg/ml, respectively. In contrast to TNF-
production, IL-1
and IL-6 production was not significantly different for preterm and
full-term infants (Table 1).
|
Adhesion receptor expression. Cord blood samples were collected from 14 full-term infants (BW, 3,213 ± 442 g; GA, 39.0 ± 1.4 weeks [P < 0.001]) and 11 preterm infants (BW, 1,359 ± 505 g; GA, 29.5 ± 3.0 weeks). MCF intensities in monocytes from full-term infants were 12.9 ± 0.5 for CD11b and 6.6 ± 1.4 for CD18. CD11b expression in monocytes from preterm infants was significantly lower, 5.1 ± 2.1 (a decrease of 60%) (P < 0.01), and CD18 expression was also significantly lower, 3.2 ± 1.5 (a decrease of 52%) (P < 0.01) (Fig. 3).
|
| |
DISCUSSION |
|---|
|
|
|---|
The preterm infant has an increased incidence and severity of
infection which is multifactorial in origin (7, 11, 13). In
our study, several aspects of the monocyte immune response were
deficient in preterm infants, specifically bactericidal function and
TNF-
secretion. In vitro we demonstrated diminished TNF-
secretion, O2
generation, and lysosomal
degranulation in adherent monocytes from preterm infants compared to
full-term infants. These functions were not diminished in freshly
isolated monocytes from preterm infants compared to those from
full-term infants. We hypothesized that a receptor important in both
adhesion and immune function may also be diminished. We observed
diminished cell surface expression of the CD11b/CD18 adhesion receptor
subunits in monocytes from preterm infants than from full-term infants.
This decreased expression is a possible mechanism for the diminished
bactericidal functions and cytokine secretion observed in our study.
These abnormalities may contribute to the increased incidence of
infection in preterm infants in vivo.
Previous studies have linked the
-2 integrin CD11b/CD18 adhesion
receptor and immune function in adults, but to date, similar investigations have not been performed with premature infants.
-2
integrins are located on all leukocytes and are involved in receptor-ligand interactions between cells. They mediate
leukocyte-leukocyte adhesion, leukocyte-endothelial cell adhesion, and
immune responses (phagocytosis, complement binding, degranulation,
cytokine secretion, and O2
production). Owen
et al. demonstrated that O2
production in
activated monocytes from adults was inhibited by monoclonal antibodies
blocking the CD11b/CD18 adhesion receptor (18). Studies of
CD18-deficient leukocytes from infants with leukocyte adhesion
deficiency demonstrated diminished O2
production and degranulation (8, 20). Fan and Edington
showed enhanced TNF-
mRNA expression and protein secretion by
LPS-stimulated monocytes when adherent to a CD11b/CD18 receptor
(6), an effect blocked by anti-CD11b and anti-CD18
monoclonal antibodies (6). These studies demonstrate that
when the CD11b/CD18 receptor was blocked or deficient, bactericidal
function and TNF-
secretion were diminished. This relationship
between immune function and adherence receptors may also be present in
preterm monocytes. Further studies are needed to determine if the
decreased expression of
-2 integrin (CD11b/CD18) adherence receptors
is a possible basis and mechanism for the decreased immune responses in
adherent monocytes from preterm infants.
In our investigations of monocyte function and cytokine secretion, we
used cells isolated on denatured type I collagen (gelatin). This
adherence step allowed the separation of monocytes from the nonadherent
lymphocyte population without using
-2 integrins (1, 9,
18). Previous studies have demonstrated that leukocytes adhere to
gelatin and collagen derivatives via
-1 integrins and that blocking
monoclonal antibodies to the
-2 integrin, CD18, do not affect
adherence of monocytes to gelatin (1, 9, 17, 18). Therefore,
we do not suspect that our isolation procedures preselected a
population of monocytes deficient in
-2 integrins. Furthermore, our
findings demonstrating decreased
-2 receptor expression in monocytes
from preterm infants were obtained with whole blood, not isolated cells.
In our assays of monocyte function, cells were stimulated with both
FMLP and PMA. FMLP binds to its specific receptor, which then triggers
protein kinase C activation and calcium mobilization, leading to
O2
generation (14). In contrast,
PMA directly stimulates protein kinase C, bypassing a cell surface
receptor. We observed decreased O2
production
by adherent monocytes from preterm infants when the cells were
stimulated with either PMA or FMLP. Additionally, decreased cell
function was observed when the LPS ligand was used to stimulate cytokine secretion. This decreased cell function observed with a number
of different ligands (PMA, FMLP, and LPS) implies that the
abnormalities observed are not receptor specific.
Decreased cell function in adherent monocytes from preterm infants was
not the result of decreased cell number. DNA analysis demonstrated
equivalent DNA content between preterm and full-term monocytes (data
not shown). In addition to DNA content, secretion of the cytokines
IL-1
and IL-6 by adherent monocytes was also equivalent in preterm
and term infants. In contrast to our findings for adherent monocytes,
O2
production and degranulation were
equivalent or enhanced in freshly isolated monocytes from preterm
infants compared to full-term infants. These findings suggest that the
necessary cellular components of the bactericidal response are present
and fully functional in monocytes from preterm infants. When monocytes
are placed in culture, the processes of adherence and differentiation
induce alterations in protein synthesis and cellular metabolism which modify bactericidal activity (3, 4, 15, 16, 24). Thus, the
decreased O2
production and degranulation
observed in preterm adherent monocytes appear to be related to
regulatory processes rather than defective or absent components of the
bactericidal response.
Finally, our observations do not rule out the possibility that there
may be subtle alterations in adherence by monocytes from preterm
infants which affect signaling pathways that regulate TNF-
secretion. Interestingly, IL-1
and IL-6 production was unaltered in
preterm cells following adherence in culture for 18 h, suggesting
different regulatory controls than for TNF-
. These findings are
similar to the results of other studies (21-23).
The findings in our study demonstrate diminished TNF-
secretion,
bactericidal function, and decreased adherence receptor expression in
monocytes from preterm infants. These in vitro abnormalities in immune
function and adhesion may contribute to the increased incidence and
severity of infection in the preterm infant in vivo. Studies of adult
monocytes have shown a relationship between the CD11b/CD18 adherence
receptor and bactericidal function and cytokine secretion. Our results
suggest that diminished expression of the CD11b/CD18 adhesion receptor
may be an important factor associated with diminished bactericidal
function and cytokine secretion in monocytes from preterm infants in
vitro. Further studies are needed to determine the potential
association between the CD11b/CD18 receptor and bactericidal function
and cytokine secretion in preterm infants.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by Wyeth-Ayerst Laboratories, the Howard Heinz endowment, General Clinical Research Center grant MO1-RR 00240 from the National Institutes of Health, and the laboratory of Steven D. Douglas, which is supported by National Institutes of Health grants MH 49981 and UO-1AI32921.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: University of Virginia, HSC, Pediatrics Box 386, Charlottesville, VA 22903. Phone: (804) 924-9114. Fax: (804) 924-2816. E-mail: dak4r{at}virginia.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Arnaout, M. A.
1990.
Structure and function of leukocyte adhesion molecules CD11/CD18.
Blood
75:1037-1050 |
| 2. | Babior, B. M. 1978. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med. 298:659-668[Medline]. |
| 3. | Cassatella, M. A., F. Bazzoni, M. A. Amezaga, and F. Rossi. 1991. Studies on the gene expression of several NADPH oxidase components. Biochem. Soc. Trans. 19:63-67[Medline]. |
| 4. |
Cassatella, M. A.,
F. Bazzoni,
R. M. Flynn,
S. Dusi,
G. Trinchieri, and F. Rossi.
1990.
Molecular basis of interferon-gamma receptor and lipopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components.
J. Biol. Chem.
265:20241-20246 |
| 5. |
Etzioni, A.
1996.
Adhesion molecules their role in health and disease.
Pediatr. Res.
39:191-198[Medline].
|
| 6. |
Fan, S. T., and T. S. Edington.
1993.
Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor- responses of monocytes.
J. Immunol.
150:2972-2980[Abstract].
|
| 7. | Gerdes, J. S. 1991. Clinicopathologic approach to the diagnosis of neonatal sepsis, p. 361-381. In R. A. Polin, and W. T. Speck (ed.), Clinics of perinatology. W. B. Saunders, Philadelphia, Pa. |
| 8. | Goodman, E. B., D. C. Anderson, and A. J. Tenner. 1995. Clq triggers neutrophil superoxide production by unique CD18-dependent mechanism. J. Leukoc. Biol. 58:168-176[Abstract]. |
| 9. | Gudewicz, P. W., M. B. Frewin, L. A. Heinel, and F. L. Minnear. 1994. Priming of human monocyte superoxide production and arachidonic acid metabolism by adherence to collagen- and basement membrane-coated surfaces. J. Leukoc. Biol. 55:423-429[Abstract]. |
| 10. | Hassan, N. F., D. E. Campbell, and S. D. Douglas. 1986. Purification of human monocytes on gelatin coated surfaces. J. Immunol. Methods 95:273-276[Medline]. |
| 11. | Hoffman, D. J., and M. C. Harris. 1996. Diagnosis of neonatal sepsis, p. 940-950. In A. R. Spitzer (ed.), Intensive care of the fetus and neonate. Mosby-Year Book, Inc., St. Louis, Mo. |
| 12. | Issekutz, A. C., E. Chuluyan, and N. Lopes. 1995. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanisms. J. Leukoc. Biol. 57:553-561[Abstract]. |
| 13. | Kilpatrick, L., and M. C. Harris. 1998. Cytokines and the inflammatory response, p. 1967-1979. In R. A. Polin, and W. W. Fox (ed.), Fetal and neonatal physiology. W. B. Saunders, Philadelphia, Pa. |
| 14. |
Korchak, H. M., and G. Weissmann.
1978.
Changes in membrane potential of human granulocytes antecede the metabolic responses to surface stimulation.
Proc. Natl. Acad. Sci. USA
75:3818-3822 |
| 15. | Musson, R. A., L. C. McPhail, H. Shafran, and R. B. Johnston, Jr. 1982. Differences in the ability of human monocytes and in vitro monocyte-derived macrophages to produce superoxide anion: studies with cells from normals and patients with chronic granulomatous disease. J. Reticuloendothel. Soc. 32:261-266. |
| 16. | Nakagawara, A., C. F. Nathan, and Z. A. Cohn. 1981. Hydrogen peroxide metabolism in human monocytes during differentiation in vitro. J. Clin. Investig. 68:1243-1252. |
| 17. | Newman, S. L., and M. A. Tucci. 1990. Regulation of human monocyte/macrophage function by extracellular matrix. J. Clin. Investig. 86:703-714. |
| 18. | Owen, C. A., E. J. Campbell, and R. A. Stockley. 1992. Monocyte adherence to fibronectin: role of CD11/CD18 integrins and relationship to other monocyte functions. J. Leukoc. Biol. 51:400-408[Abstract]. |
| 19. | Ruoslahti, E. 1990. Integrins. J. Clin. Investig. 87:1-5. |
| 20. | Todd, R. F., and D. R. Freyer. 1988. The CD11/CD18 leukocyte glycoprotein deficiency, p. 13-31. In J. T. Curnutte (ed.), Hematology/oncology clinics of North America. W. B. Saunders, Philadelphia, Pa. |
| 21. | Weatherspoon, K. B., and E. A. Rich. 1989. Tumor necrosis factor/cachectin and interleukin-1 secretion by cord blood monocytes from premature and term neonates. Pediatr. Res. 25:342-346[Medline]. |
| 22. | Wilmott, R. W., M. C. Harris, K. M. Haines, and S. D. Douglas. 1987. Interleukin-1 activity from human cord blood monocytes. Diagn. Clin. Immunol. 5:201-204[Medline]. |
| 23. | Yoder, M. C., H. F. Hassan, and S. D. Douglas. 1992. Mononuclear phagocyte system, p. 1428-1460. In R. A. Polin, and W. W. Fox (ed.), Fetal and neonatal physiology. W. B. Saunders, Philadelphia, Pa. |
| 24. | Zuckerman, S. H., S. K. Ackerman, and S. D. Douglas. 1979. Long-term human peripheral blood monocyte cultures: establishment, metabolism, and morphology of primary monocyte-macrophage cell cultures. Immunology 38:401-411[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |